{"id":"https://openalex.org/W2418655795","doi":"https://doi.org/10.1016/j.jval.2015.09.2600","title":"Challenges to The Economic Modelling of Macular Oedema Due to Retinal Vein Occlusion And Diabetes","display_name":"Challenges to The Economic Modelling of Macular Oedema Due to Retinal Vein Occlusion And Diabetes","publication_year":2015,"publication_date":"2015-10-20","ids":{"openalex":"https://openalex.org/W2418655795","doi":"https://doi.org/10.1016/j.jval.2015.09.2600","mag":"2418655795"},"language":"en","primary_location":{"id":"doi:10.1016/j.jval.2015.09.2600","doi":"https://doi.org/10.1016/j.jval.2015.09.2600","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2015.09.2600","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.jval.2015.09.2600","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109234655","display_name":"C. Almond","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159506","display_name":"BresMed","ror":"https://ror.org/05fd45014","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210159506"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C Almond","raw_affiliation_strings":["BresMed, Sheffield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BresMed, Sheffield, UK","institution_ids":["https://openalex.org/I4210159506"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110047250","display_name":"N.J. Brereton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159506","display_name":"BresMed","ror":"https://ror.org/05fd45014","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210159506"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"N Brereton","raw_affiliation_strings":["BresMed, Sheffield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BresMed, Sheffield, UK","institution_ids":["https://openalex.org/I4210159506"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210159506"],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.3206224,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"7","first_page":"A697","last_page":"A697"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.5957000255584717,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.5957000255584717,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.38600000739097595,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11438","display_name":"Retinal Imaging and Analysis","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/macular-edema","display_name":"macular edema","score":0.8460000157356262},{"id":"https://openalex.org/keywords/retinal-vein-occlusion","display_name":"retinal vein occlusion","score":0.9909999966621399},{"id":"https://openalex.org/keywords/diabetic-macular-edema","display_name":"diabetic macular edema","score":0.9990000128746033},{"id":"https://openalex.org/keywords/economic-modeling","display_name":"economic modeling","score":0.8709999918937683},{"id":"https://openalex.org/keywords/nice-technology-appraisal","display_name":"NICE technology appraisal","score":0.8820000290870667},{"id":"https://openalex.org/keywords/bilateral-treatment","display_name":"bilateral treatment","score":0.492000013589859},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.8870000243186951},{"id":"https://openalex.org/keywords/aflibercept","display_name":"aflibercept","score":0.9950000047683716},{"id":"https://openalex.org/keywords/model-uncertainty","display_name":"model uncertainty","score":0.453000009059906}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7663397789001465},{"id":"https://openalex.org/C2778749236","wikidata":"https://www.wikidata.org/wiki/Q4689286","display_name":"Aflibercept","level":4,"score":0.6976131200790405},{"id":"https://openalex.org/C2779256446","wikidata":"https://www.wikidata.org/wiki/Q33959","display_name":"Nice","level":2,"score":0.63355553150177},{"id":"https://openalex.org/C2778844676","wikidata":"https://www.wikidata.org/wiki/Q190831","display_name":"Central retinal vein occlusion","level":4,"score":0.6148789525032043},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.5655379891395569},{"id":"https://openalex.org/C119767625","wikidata":"https://www.wikidata.org/wiki/Q618211","display_name":"Optometry","level":1,"score":0.5070745944976807},{"id":"https://openalex.org/C2780261187","wikidata":"https://www.wikidata.org/wiki/Q4956400","display_name":"Branch retinal vein occlusion","level":4,"score":0.4835812449455261},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.46279358863830566},{"id":"https://openalex.org/C2776268601","wikidata":"https://www.wikidata.org/wiki/Q968808","display_name":"Occlusion","level":2,"score":0.4612495005130768},{"id":"https://openalex.org/C2908732032","wikidata":"https://www.wikidata.org/wiki/Q5062148","display_name":"Retinal Vein","level":3,"score":0.4540255665779114},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.3285820484161377},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.31750357151031494},{"id":"https://openalex.org/C2780347916","wikidata":"https://www.wikidata.org/wiki/Q1813737","display_name":"Macular edema","level":3,"score":0.2963310480117798},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.102487713098526},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jval.2015.09.2600","doi":"https://doi.org/10.1016/j.jval.2015.09.2600","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2015.09.2600","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jval.2015.09.2600","doi":"https://doi.org/10.1016/j.jval.2015.09.2600","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2015.09.2600","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2540823010","https://openalex.org/W4417481380","https://openalex.org/W2995606252","https://openalex.org/W7100861498","https://openalex.org/W2065815375","https://openalex.org/W2005486200","https://openalex.org/W2924670922","https://openalex.org/W2076843885","https://openalex.org/W2426897211","https://openalex.org/W2008658215"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-16T18:09:00.828671","created_date":"2016-06-24T00:00:00"}